Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate

BACKGROUND: The ROX index (ratio of pulse oximetry/FIO(2) to respiratory rate) has been validated to predict high flow nasal cannula therapy (HFNC) outcomes in patients with pneumonia. We evaluated a modified ROX index incorporating heart rate (HR) in patients initiated on HFNC for acute hypoxemic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Ken Junyang, Chai, Hui Zhong, Ong, Thun How, Sewa, Duu Wen, Phua, Ghee Chee, Tan, Qiao Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310118/
https://www.ncbi.nlm.nih.gov/pubmed/32587703
http://dx.doi.org/10.1186/s40560-020-00458-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310118/
https://www.ncbi.nlm.nih.gov/pubmed/32587703
http://dx.doi.org/10.1186/s40560-020-00458-z

Ejemplares similares